Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesothelioma; Peritoneum”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02834169
What this trial is testing

French National Registry of Rare Peritoneal Surface Malignancies

Who this might be right for
Rare Peritoneal Surface MalignanciesPseudomyxoma PeritoneiPeritoneal Mesothelioma+5 more
Hospices Civils de Lyon 2,171
Early research (Phase 1)Study completedNCT03023319
What this trial is testing

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungMesotheliomaBladder Cancer+5 more
Nagla Abdel Karim 6
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Not applicableEnded earlyNCT00028782
What this trial is testing

EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer

Who this might be right for
Advanced Malignant MesotheliomaLocalized Malignant MesotheliomaMalignant Ascites+2 more
National Cancer Institute (NCI) 80
Not applicableLooking for participantsNCT02073500
What this trial is testing

Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies

Who this might be right for
Pseudomyxoma PeritoneiColorectal CarcinomaOvarian Carcinoma+1 more
Oslo University Hospital 300
Early research (Phase 1)Study completedNCT00398138
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Who this might be right for
LeukemiaLung CancerMalignant Mesothelioma+2 more
Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT01592383
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma

Who this might be right for
Malignant Peritoneal Mesothelioma
University of Chicago 2
Not applicableStudy completedNCT01812148
What this trial is testing

Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

Who this might be right for
Peritoneal Mesotheliomas
Maisonneuve-Rosemont Hospital 19
Testing effectiveness (Phase 2)Study completedNCT02399371
What this trial is testing

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Biphasic MesotheliomaEpithelioid MesotheliomaPeritoneal Malignant Mesothelioma+7 more
University of Chicago 65
Not applicableLooking for participantsNCT07330271
What this trial is testing

PTC-Guided Therapy for Peritoneal Mesothelioma

Who this might be right for
Peritoneal Mesothelioma
Beijing Tsinghua Chang Gung Hospital 347
Early research (Phase 1)Study completedNCT03507452
What this trial is testing

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Who this might be right for
Advanced Recurrent Malignant Pleural Epithelioid MesotheliomaAdvanced Recurrent Malignant Peritoneal Epithelioid MesotheliomaAdvanced Recurrent Serous Ovarian Cancer+1 more
Bayer 36
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Looking for participantsNCT06543069
What this trial is testing

Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM

Who this might be right for
Malignant Peritoneal Mesothelioma, Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 28
Not applicableStudy completedNCT03034850
What this trial is testing

Thrombin Generation and Platelet Activation in CRS/HIPEC

Who this might be right for
Mesothelioma; PeritoneumPseudomyxoma PeritoneiPeritoneal Carcinomatosis
Ziekenhuis Oost-Limburg 27
Early research (Phase 1)UnknownNCT04000906
What this trial is testing

PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis

Who this might be right for
Peritoneal Carcinomatosis
University Hospital, Geneva 18
Testing effectiveness (Phase 2)Study completedNCT01160458
What this trial is testing

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy

Who this might be right for
Pleural MesotheliomaPeritoneal Mesothelioma
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Temporarily pausedNCT05337735
What this trial is testing

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Who this might be right for
Microsatellite High CancersPeritoneal MesotheliomaExtrapulmonary High Grade+5 more
M.D. Anderson Cancer Center 140
Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 884
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Early research (Phase 1)Ended earlyNCT02029690
What this trial is testing

Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Who this might be right for
Pleural Mesothelioma Malignant AdvancedPeritoneal Mesothelioma Malignant AdvancedNon-squamous Non-small Cell Lung Carcinoma+4 more
Polaris Group 85
Next Page